1. Home
  2. CELZ vs AEON Comparison

CELZ vs AEON Comparison

Compare CELZ & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELZ
  • AEON
  • Stock Information
  • Founded
  • CELZ 1998
  • AEON N/A
  • Country
  • CELZ United States
  • AEON United States
  • Employees
  • CELZ N/A
  • AEON N/A
  • Industry
  • CELZ Biotechnology: Pharmaceutical Preparations
  • AEON Biotechnology: Pharmaceutical Preparations
  • Sector
  • CELZ Health Care
  • AEON Health Care
  • Exchange
  • CELZ Nasdaq
  • AEON Nasdaq
  • Market Cap
  • CELZ 5.5M
  • AEON 5.7M
  • IPO Year
  • CELZ N/A
  • AEON N/A
  • Fundamental
  • Price
  • CELZ $2.39
  • AEON $0.82
  • Analyst Decision
  • CELZ
  • AEON Strong Buy
  • Analyst Count
  • CELZ 0
  • AEON 1
  • Target Price
  • CELZ N/A
  • AEON $360.00
  • AVG Volume (30 Days)
  • CELZ 46.0K
  • AEON 1.9M
  • Earning Date
  • CELZ 05-09-2025
  • AEON 05-14-2025
  • Dividend Yield
  • CELZ N/A
  • AEON N/A
  • EPS Growth
  • CELZ N/A
  • AEON N/A
  • EPS
  • CELZ N/A
  • AEON 73.23
  • Revenue
  • CELZ $14,000.00
  • AEON N/A
  • Revenue This Year
  • CELZ N/A
  • AEON N/A
  • Revenue Next Year
  • CELZ N/A
  • AEON N/A
  • P/E Ratio
  • CELZ N/A
  • AEON $0.01
  • Revenue Growth
  • CELZ 55.56
  • AEON N/A
  • 52 Week Low
  • CELZ $1.69
  • AEON $0.38
  • 52 Week High
  • CELZ $6.90
  • AEON $269.28
  • Technical
  • Relative Strength Index (RSI)
  • CELZ 64.49
  • AEON 67.31
  • Support Level
  • CELZ $2.22
  • AEON $0.53
  • Resistance Level
  • CELZ $2.44
  • AEON $0.85
  • Average True Range (ATR)
  • CELZ 0.12
  • AEON 0.08
  • MACD
  • CELZ 0.05
  • AEON 0.05
  • Stochastic Oscillator
  • CELZ 91.04
  • AEON 92.78

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

About AEON AEON Biopharma Inc.

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Share on Social Networks: